GEARING UP FOR WWJ 950'S THAW RADIOTHON: DONATE ONLINE HERE  

Immunotherapy

Tolera Therapeutics Closes Series B-3 Financing, Raises $5.5MTolera Therapeutics Inc., a privately held biotechnology company focusing on the development of immunotherapeutics directed at the transplantation, autoimmune and oncology markets, announced today that it has closed its Series B-3 financing.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen